Tag: ESMO
Nanobiotix: new clinical results at ESMO – 10/23/2023 at 12:15 p.m.
(CercleFinance.com) – Nanobiotix rose 4% this Monday on the Paris Stock Exchange after announcing new clinical results at the congress of the European Society of Oncology (ESMO). The conclusions of…
Median Technologies: results of its AI model presented at Esmo at the end of October – 10/17/2023 at 6:26 p.m.
(AOF) – Median Technologies announces that the first results of its iBiopsy HCC detection AI model will be presented at the annual congress of ESMO (European Society for Medical Oncology),…
Median Technologies: results of its AI model presented at Esmo at the end of October
(AOF) – Median Technologies announces that the first results of its iBiopsy HCC detection AI model will be presented at the annual congress of ESMO (European Society for Medical Oncology),…
J&J: to present new data at ESMO
(CercleFinance.com) – Johnson & Johnson announced that nine oral presentations will be made at the 2023 congress of the European Society of Medical Oncology (ESMO). A total of 19 studies,…
Johnson & Johnson: To present new data at ESMO
Read also (CercleFinance.com) – Johnson & Johnson announced that nine oral presentations will be made at the 2023 congress of the European Society of Medical Oncology (ESMO). A total of…
Pfizer: Will present data to ESMO
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Innate Pharma on the rise: several presentations planned at the Esmo congress – 10/16/2023 at 09:48
(AOF) – Innate Pharma (+3% to 2.23 euros) posts one of the strongest increases in the SRD market after the announcement that several abstracts are selected for the European Society…
Transgene Confirms the Potential of the Intravenous Route of its Invir.IO™ Oncolytic Viruses against Solid Tumors with TG6002 Phase I Data Presented at ESMO Congress 2022 – 09/12/2022 at 08:00
Additional positive TG6002 Phase I data show that the oncolytic virus is able to reach the tumor, replicate and express its payload in all patients when administered intravenously Strasbourg, France,…
Phase I data of TG6002 presented at ESMO 2022 confirms the potential of Transgene’s Invir.IO™ oncolytic viruses administered intravenously to treat solid tumors – 09/12/2022 at 08:00
The new positive data from the Phase I trial of TG6002 show in all patients that this oncolytic virus, administered intravenously, is capable of reaching the tumor, multiplying there and…
Median Technologies: two presentations scheduled at the ESMO congress in Paris
By Olivier Cheilan Published on 09/06/2022 at 5:56 p.m. Photo credit © Reuters …
Median Technologies will make two presentations about iCRO and iBiopsy® at the ESMO 2022 Congress from September 9 to 13 in Paris – 09/06/2022 at 17:45
Press release – For immediate release September 6, 2022 – 5:45 p.m. CEST Median Technologies will make two presentations regarding iCRO and iBiopsy® at the ESMO 2022 Congress from September…
Innate pharma: Several presentations at the ESMO congress
Read also (CercleFinance.com) – Innate Pharma announced on Monday its intention to make several presentations at the ESMO congress, a conference devoted to oncology which will open at the end…